Companies / BOC Sciences / Elranatamab
BOC Sciences

Elranatamab | BOC Sciences

Elranatamab is a humanized bispecific IgG2 antibody targeting B cell maturation antigen on myeloma cells and CD3 on T cells. Elranatamab activates and directs T cells to induce a selective cytotoxic T cell response against myeloma cells.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.